Krönke at al. report increased ubiquitination of CK1α that correlates with reduced levels of CK1α protein in AML cell lines after treatment with lenalidomide without altering its transcript levels (Figure 4B) [59]. The gene discussed is CSNK1A1; the disease is acute myeloid leukemia.